The results showed that PZH or PD-1/PD-L1 blocking antibody stalled the tumor growth and size (Figures 6A,B), whereas the combination group exhibited a more powerful tumor suppression compared to monotherapy with either agent (Figures 6A,B). This evidence concerns the gene CD274 and neoplasm.